In Kyung Jeong
Kyung Hee University Hospital at Gangdong · Kyung Hee University Hospital at Gangdong in Korea
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name In Kyung Jeong as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 06:38 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT07365358 · Evaluate the Efficacy and Safety of Empagliflozin or Glimepiride Combination Therapy in Type 2 Diabetes Mellitus PatientsChong Kun Dang Pharmaceutical · not yet recruiting · Diabete Type 2 · principal investigator
- Ph2NCT06712615 · Phase II Study of PG-102(MG12) Compared With Placebo in Obesity and Type 2 DiabetesProGen. Co., Ltd. · active not recruiting · Type 2 Diabetes Mellitus (T2DM), Obesity Type 2 Diabetes Mellitus · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 06:38 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 2 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 06:38 UTC. The ranking covers the 200 most relevant of 23 PubMed records, and a shared surname and initials can bring in a namesake. All 23 on PubMed
- Insulin-sensitizing effects of exercise on adiponectin and retinol-binding protein-4 concentrations in young and middle-aged women.J Clin Endocrinol Metab · 200885 citationsRCR 2.3
- Effect of Dapagliflozin as an Add-on Therapy to Insulin on the Glycemic Variability in Subjects with Type 2 Diabetes Mellitus (DIVE): A Multicenter, Placebo-Controlled, Double-Blind, Randomized Study.Diabetes Metab J · 202121 citationsRCR 1.3
- A multicentre, double-blind, placebo-controlled, randomized, parallel comparison, phase 3 trial to evaluate the efficacy and safety of pioglitazone add-on therapy in type 2 diabetic patients treated with metformin and dapagliflozin.Diabetes Obes Metab · 202421 citationsRCR 3.6
- The effects of Acanthopanax senticosus extract on bone turnover and bone mineral density in Korean postmenopausal women.J Bone Miner Metab · 200920 citationsRCR 0.8
- Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial.Diabetes Metab J · 201917 citationsRCR 1.0
- Efficacy and Safety of Enavogliflozin versus Dapagliflozin as Add-on to Metformin in Patients with Type 2 Diabetes Mellitus: A 24-Week, Double-Blind, Randomized Trial.Diabetes Metab J · 202317 citationsRCR 1.9
- 14 citationsRCR 0.8
- [Optimal cut-off value of PIVKA-II for diagnosis of hepatocellular carcinoma--using ROC curve].Korean J Hepatol · 200611 citationsRCR 0.3
- Efficacy and Safety of Omega-3 Fatty Acids in Patients Treated with Statins for Residual Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.Diabetes Metab J · 20209 citationsRCR 0.5
- Effects of dapagliflozin compared with glimepiride on body composition in Asian patients with type 2 diabetes inadequately controlled with metformin: The BEYOND study.Diabetes Obes Metab · 20239 citationsRCR 1.2